THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging

Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 1,931

Frequency: Quarterly

pISSN 1824-4785

eISSN 1827-1936

Most read articles over the last three weeks

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):136-49
Molecular imaging of bone metastases using tumor-targeted tracers
Najme KARAMZADE-ZIARATI, Reyhaneh MANAFI-FARID, Bahar ATAEINIA, Werner LANGSTEGER, Christian PIRICH, Felix M. MOTTAGHY, Mohsen BEHESHTI *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 June;64(2):143-51
Prognostic and predictive role of the tumor immune landscape
John B. HAANEN *, Christian U. BLANK

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):235-52
The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancer
Manuel WEBER, Ina BINSE, James NAGARAJAH, Andreas BOCKISCH, Ken HERRMANN, Walter JENTZEN *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 June;64(2):162-74
The LIPI score and inflammatory biomarkers for selection of patients with solid tumors treated with checkpoint inhibitors
Jose C. BENITEZ, Gonzalo RECONDO, Elie RASSY, Laura MEZQUITA *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 December;63(4):355-70
CT radiomics and PET radiomics: ready for clinical implementation?
Marta BOGOWICZ *, Diem VUONG, Martin W. HUELLNER, Matea PAVIC, Nicolaus ANDRATSCHKE, Hubert S. GABRYS, Matthias GUCKENBERGER, Stephanie TANADINI-LANG

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):267-70
Advanced differentiated thyroid cancer: when to stop radioiodine?
Luca GIOVANELLA *, Douglas van NOSTRAND

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):229-34
Radioiodine therapy of advanced differentiated thyroid cancer: clinical considerations and multidisciplinary approach
Luca GIOVANELLA *, Lorenzo SCAPPATICCIO

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):239-53
Conventional and advanced magnetic resonance imaging in patients with high-grade glioma
Whitney B. POPE *, Garth BRANDAL

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 June;62(2):152-64
How to use PET/CT in the evaluation of response to radiotherapy
Pierre DECAZES *, Sébastien THUREAU, Bernard DUBRAY, Pierre VERA

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 December;63(4):347-54
Are radiomics ready for clinical prime-time in PET/CT imaging?
Catherine CHEZE LE REST *, Roland HUSTINX